Andrew Brohl | Moffitt

Dr. Andrew Brohl, MD

Claim this profile

Moffitt Cancer Center

Expert in Skin Cancer
Studies Merkel Cell Carcinoma
19 reported clinical trials
30 drugs studied

Area of expertise

1

Skin Cancer

Global Leader

Andrew Brohl, MD has run 13 trials for Skin Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II
2

Merkel Cell Carcinoma

Andrew Brohl, MD has run 6 trials for Merkel Cell Carcinoma. Some of their research focus areas include:

Stage IV
Stage III
Stage II

Affiliated Hospitals

Image of trial facility.

Moffitt Cancer Center

Image of trial facility.

Moffitt Cancer Center - McKinley Campus

Clinical Trials Andrew Brohl, MD is currently running

More about Andrew Brohl, MD

Clinical Trial Related

6 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 5 Active Clinical Trials

Treatments Andrew Brohl, MD has experience with

  • Nivolumab
  • Pembrolizumab
  • Ipilimumab
  • Avelumab
  • Interleukin-2
  • Cemiplimab-Rwlc

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Andrew Brohl, MD specialize in?

Is Andrew Brohl, MD currently recruiting for clinical trials?

Are there any treatments that Andrew Brohl, MD has studied deeply?

What is the best way to schedule an appointment with Andrew Brohl, MD?

What is the office address of Andrew Brohl, MD?

Is there any support for travel costs?